Nerve Stimulation for Urinary Incontinence - Medicare Advantage

This policy addresses Medicare Advantage coverage for nerve stimulation therapies for urinary and fecal incontinence — primarily sacral nerve stimulation, posterior tibial nerve stimulation, and implanted bladder stimulators — for conditions such as overactive bladder, urge urinary incontinence, and urinary retention. Coverage is governed by Medicare NCDs/LCDs and varies by MAC jurisdiction, replacement devices must be FDA‑approved, and the provided excerpt contains no specific prior‑therapy, trial‑stimulation, or other clinical criteria (with implanted PTNS described as a novel/experimental technology).

"Inferred from title: Sacral nerve stimulation for the treatment of urinary incontinence."

Sign up to see full coverage criteria, indications, and limitations.